Literature DB >> 10934160

Patterns of chromosomal imbalances in parathyroid carcinomas.

S Kytölä1, F Farnebo, T Obara, J Isola, L Grimelius, L O Farnebo, K Sandelin, C Larsson.   

Abstract

In this study we have characterized chromosomal imbalances in a panel of 29 parathyroid carcinomas using comparative genomic hybridization (CGH). The most frequently detected imbalances were losses of 1p and 13q that were seen in >40% of the cases. The commonly occurring regions of loss were assigned to 1p21-p22 (41%), 13q14-q31 (41%), 9p21-pter (28%), 6q22-q24 (24%), and 4q24 (21%), whereas gains preferentially involved 19p (45%), Xc-q13 (28%), 9q33-qter (24%), 1q31-q32 (21%) and 16p (21%). The distribution of CGH alterations supports the idea of a progression of genetic events in the development of parathyroid carcinoma, where gains of Xq and 1q would represent relatively early events that are followed by loss of 13q, 9p, and 1p, and by gain of 19p. A sex-dependent distribution was also evident for two of the common alterations with preferential gain of 1q in female cases and of Xq in male cases. When the CGH profiles for the 29 carcinomas were compared with our previously published results for sporadic parathyroid adenomas, highly significant differences were revealed. Loss of 1p, 4q, and 13q as well as gains of 1q, 9q, 16p, 19p and Xq were significantly more common in the carcinomas than in the adenomas. In contrast, loss of the 11q13 region, which is the most common CGH abnormality in sporadic adenomas, was not detected in any of the carcinomas. Taken together, the findings identify several candidate locations for tumor suppressor genes and oncogenes that are potentially involved in parathyroid carcinogenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10934160      PMCID: PMC1850113          DOI: 10.1016/S0002-9440(10)64568-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?

Authors:  C Dotzenrath; B T Teh; F Farnebo; K Cupisti; A Svensson; A Toell; P Goretzki; C Larsson
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

2.  Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Authors:  M Kaghad; H Bonnet; A Yang; L Creancier; J C Biscan; A Valent; A Minty; P Chalon; J M Lelias; X Dumont; P Ferrara; F McKeon; D Caput
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

3.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

Review 4.  Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.

Authors:  V L Cryns; S M Yi; H Tahara; R D Gaz; A Arnold
Journal:  Genes Chromosomes Cancer       Date:  1995-05       Impact factor: 5.006

5.  p53 abnormalities in human parathyroid carcinoma.

Authors:  V L Cryns; M P Rubio; A D Thor; D N Louis; A Arnold
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

6.  Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

Authors:  J Isola; S DeVries; L Chu; S Ghazvini; F Waldman
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.

Authors:  J Szabó; B Heath; V M Hill; C E Jackson; R J Zarbo; L E Mallette; S L Chew; G M Besser; R V Thakker; V Huff
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

8.  Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.

Authors:  H Tahara; A P Smith; R D Gas; V L Cryns; A Arnold
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

9.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

Authors:  K Heselmeyer; E Schröck; S du Manoir; H Blegen; K Shah; R Steinbeck; G Auer; T Ried
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.

Authors:  V L Cryns; A Thor; H J Xu; S X Hu; M E Wierman; A L Vickery; W F Benedict; A Arnold
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

View more
  25 in total

1.  Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.

Authors:  Ralph Schneider; Stefanie Bartsch-Herzog; Annette Ramaswamy; Detlef K Bartsch; Elias Karakas
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

2.  Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.

Authors:  Jessica Costa-Guda; Yasuo Imanishi; Nallasivam Palanisamy; Norihiko Kawamata; H Phillip Koeffler; R S K Chaganti; Andrew Arnold
Journal:  Endocrine       Date:  2013-02-24       Impact factor: 3.633

3.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Authors:  Gabriela Vaz Meirelles; Arina Marina Perez; Edmárcia Elisa de Souza; Fernanda Luisa Basei; Priscila Ferreira Papa; Talita Diniz Melo Hanchuk; Vanessa Bomfim Cardoso; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2014-05-26

5.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 6.  Genetics of Hyperparathyroidism, Including Parathyroid Cancer.

Authors:  William F Simonds
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

Review 7.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

Review 8.  Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma.

Authors:  Ronald A Delellis
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

9.  HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.

Authors:  V M Howell; C J Haven; K Kahnoski; S K Khoo; D Petillo; J Chen; G J Fleuren; B G Robinson; L W Delbridge; J Philips; A E Nelson; U Krause; K Hammje; H Dralle; C Hoang-Vu; O Gimm; D J Marsh; H Morreau; B T Teh
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 10.  Germinoma in the basal ganglia with an abnormal karyotype: case report and review of the literature.

Authors:  En Xu; Xiaojuan Wang; Zhuofang Hao; Zheng Chen; Xuefen Lu
Journal:  Childs Nerv Syst       Date:  2009-10-30       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.